Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
Clinical trial NCT05411887 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05411887
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-20
- Primary completion
- 2025-03-31
- Enrollment
- 2845
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.